Скрининг тревожных и депрессивных расстройств при эпилепсии: современное состояние проблемы
Рекомендуемое оформление библиографической ссылки:
Зинчук М.С., Кустов Г.В., Пашнин Е.В., Войнова Н.И., Ридер Ф.К., Аведисова А.С., Гехт А.Б. Скрининг тревожных и депрессивных расстройств при эпилепсии: современное состояние проблемы // Российский психиатрический журнал. 2021. №3. С. 87-97.
В научном обзоре с целью оценки проблемы диагностики и скрининга тревожных и депрессивных расстройств среди пациентов с эпилепсией выполнен поиск наиболее распространённых и надёжных диагностических инструментов. Представлены наиболее часто используемые психометрические шкалы с описанием их особенностей в отношении диагностики депрессии и тревожных расстройств в популяции пациентов с эпилепсией. Рассмотрены тенденции в разработке специфичных для данной популяции пациентов опросников, а также даны рекомендации по их применению в российской популяции пациентов с эпилепсией.
Ключевые слова тревожные расстройства; депрессия; эпилепсия; психометрические шкалы; самоопросники
1. Fiordelli E, Beghi E, Bogliun G, Crespi V. Epilepsy and psychiatric disturbance. A cross-sectional study. Br J Psychiatry. 1993;163:446–50. DOI: https://doi.org/10.1192/bjp.163.4.446 2. Beghi E, Spagnoli P, Airoldi L, et al. Emotional and affective disturbances in patients with epilepsy. Epilepsy Behav. 2002;3(3):255–61. DOI: https://doi.org/10.1016/s1525-5050(02)00008-2 3. Scott AJ, Sharpe L, Hunt C, et al. Anxiety and depressive disorders in people with epilepsy: a meta-analysis. Epilepsia. 2017;58(6):973–82. DOI: https://doi.org/10.1111/epi.13769 4. Clancy MJ, Clarke MC, Connor DJ, et al. The prevalence of psychosis in epilepsy; a systematic review and meta-analysis. BMC Psychiatry. 2014;14(1):1–9. DOI: https://doi.org/10.1186/1471-244X-14-75 5. Kutlubaev M, Xu Y, Hackett M, et al. Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: Systematic review and meta-analysis of frequency, correlates, and outcomes. Epilepsy Behav. 2018;89:70–8. DOI: https://doi.org/10.1016/j.yebeh.2018.10.010 6. Pompili M, Girardi P, Tatarelli R. Death from suicide versus mortality from epilepsy in the epilepsies: a meta-analysis. Epilepsy Behav. 2006;9(4):641–8. DOI: https://doi.org/10.1016/j.yebeh.2006.06.019 7. Abraham N, Buvanaswari P, Rathakrishnan R, et al. A meta-analysis of the rates of suicide ideation, attempts and deaths in people with epilepsy. Int J Environ Res Public Health. 2019;16(8):1451. DOI: https://doi.org/10.3390/ijerph16081451 8. Friedman D, Spruill TM, Liu H, et al. Depressive symptoms and suicidality among individuals with epilepsy enrolled in self-management studies: results from the US Centers for Disease Control and Prevention Managing Epilepsy Well (MEW) Network. Epilepsy Behav. 2018;87:235–40. DOI: https://doi.org/10.1016/j.yebeh.2018.06.024 9. Zinchuk MS, Rider FK, Kustov GV, et al. [Suicidality in epilepsy: epidemiology and clinical risk factors]. Zh Nevrol Psikhiatr Im SS Korsakova. 2018;118(10–2):45–52. (In Russ.) DOI: https://doi.org/10.17116/jnevro201811810245 10. Lin CY, Harnod T, Lin CL, et al. Differences in Incidence and Risks of Suicide Attempt and Suicidal Drug Overdose between Patients with Epilepsy with and without Comorbid Depression. Int J Environ Res Public Health. 2019;16(22):4533. DOI: https://doi.org/10.3390/ijerph16224533 11. Kanner AM, Schachter SC, Barry JJ, et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav. 2012;24(2):156–68. DOI: https://doi.org/10.1016/j.yebeh.2012.01.007 12. Zinchuk MS, Guekht AB, Gulyaeva NV, et al. [Biological basis of suicidal behavior]. Zh Nevrol Psikhiatr Im SS Korsakova. 2016;116(8):94–101. (In Russ.) DOI: https://doi.org/10.17116/jnevro20161168194-101 13. Rider F, Danilenko O, Grishkina M, et al. Depression and Epilepsy: Comorbidity, Pathogenetic Similarity, and Principles of Treatment. Neurosci Behav Physiol. 2017;48(1):78–82. 14. Assenza G, Tombini M, Lanzone J, et al. Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review. Neurol Sci. 2020;41(11):3075–84. DOI: https://doi.org/10.1007/s10072-020-04479-2 15. Solmi M, Veronese N, Zaninotto L, et al. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. CNS Spectr. 2016;21(5):403–18. DOI: https://doi.org/10.1017/S1092852916000523 16. Rider FK, Danilenko OA, Grishkina MN, et al. [Depression and epilepsy: comorbidities, pathogenesis, principles of therapy]. Zh Nevrol Psikhiatr Im SS Korsakova. 2016;116(9–2):19–24. (In Russ.) DOI: https://doi.org/10.17116/jnevro20161169219-24 17. Rider FK, Gersamija AG. Priverzhennost' k lecheniju u pacientov s jepilepsiej: prichiny, metody ocenki, strategii uluchshenija. In: Guseva EI, Geht AB editors. Mul'tidisciplinarnye problemy lechenija i profilaktiki boleznej mozga. Moscow; 2019. p. 299–312. (In Russ.) 18. Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand. 2004;110(4):207–20. DOI: https://doi.org/10.1111/j.1600-0404.2004.00324.x 19. de Oliveira GN, Kummer A, Salgado JV, et al. Psychiatric disorders in temporal lobe epilepsy: an overview from a tertiary service in Brazil. Seizure. 2010;19(8):479–84. DOI: https://doi.org/10.1016/j.seizure.2010.07.004 20. Fiest KM, Dykeman J, Patten SB, et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology. 2013;80(6):590–9. DOI: https://doi.org/10.1212/WNL.0b013e31827b1ae0 21. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13. DOI: https://doi.org/10.1046/j.1525-1497.2001.016009606.x 22. Pogosova N, Dovzhenko T, Babin A, et al. [Russian version of phq-2 and 9 questionnaires: sensitivity and specificity in detection of depression in outpatient general medical practice]. Kardiovaskuljarnaja terapija i profilaktika [Cardiovascular Therapy and Prevention]. 2014;13(3):18–24. (In Russ.) 23. Rathore JS, Jehi LE, Fan Y, et al. Validation of the Patient Health Questionnaire-9 (PHQ-9) for depression screening in adults with epilepsy. Epilepsy Behav. 2014;37:215–20. DOI: https://doi.org/10.1016/j.yebeh.2014.06.030 24. Olssøn I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5(1):1–7. DOI: https://doi.org/10.1186/1471-244X-5-46 25. Fiest KM, Patten SB, Wiebe S, et al. Validating screening tools for depression in epilepsy. Epilepsia. 2014;55(10):1642–50. DOI: https://doi.org/10.1111/epi.12754 26. Mula M, Iudice A, La Neve A, et al. Validation of the Hamilton Rating Scale for Depression in adults with epilepsy. Epilepsy Behav. 2014;41:122–5. DOI: https://doi.org/10.1016/j.yebeh.2014.08.029 27. Gandy M, Sharpe L, Perry KN, et al. Assessing the efficacy of 2 screening measures for depression in people with epilepsy. Neurology. 2012;79(4):371–5. DOI: https://doi.org/10.1212/WNL.0b013e318260cbfc 28. Kim DH, Kim YS, Yang TW, et al. Optimal cutoff score of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) for detecting major depressive disorder: A meta-analysis. Epilepsy Behav. 2019;92:61–70. DOI: https://doi.org/10.1016/j.yebeh.2018.12.006 29. Gill SJ, Lukmanji S, Fiest KM, et al. Depression screening tools in persons with epilepsy: A systematic review of validated tools. Epilepsia. 2017;58(5):695–705. DOI: https://doi.org/10.1111/epi.13651 30. Al-Asmi A, Dorvlo AS, Burke DT, et al. The detection of mood and anxiety in people with epilepsy using two-phase designs: experiences from a tertiary care centre in Oman. Epilepsy Res. 2012;98(2–3):174–81. DOI: https://doi.org/10.1016/j.eplepsyres.2011.09.012 31. Beck A. An Inventory for Measuring Depression. Arch Gen Psychiatry. 1961;4(6):561–71. DOI: https://doi.org/10.1001/archpsyc.1961.01710120031004 32. Andrjushhenko AV, Drobizhev MJu, Dobrovol'skij AV. [A comparative validation of the scale CES-D, BDI, and HADS(d) in diagnosis of depressive disorders in general practice]. Zh Nevrol Psikhiatr Im SS Korsakova. 2003;103(5):11–8. (In Russ.) PMID: 12789819 33. de Oliveira G, Araujo Filho G, Kummer A, et al. Inventário de Depressão de Beck (BDI) e Escala de Avaliação de Depressão de Hamilton (HAM-D) em pacientes com epilepsia. J Bras Psiquiatr. 2011;60(2):131–4. 34. Gorenstein C, Andrade L, Vieira Filho AH, et al. Psychometric properties of the Portuguese version of the Beck Depression Inventory on Brazilian college students. J Clin Psychol. 1999;55(5):553–62. DOI: https://doi.org/10.1002/(sici)1097-4679(199905)55:5<553::aid-jclp3>3.0.co;2-d 35. de Oliveira GN, Kummer A, Salgado JV, et al. Suicidality in temporal lobe epilepsy: measuring the weight of impulsivity and depression. Epilepsy Behav. 2011;22(4):745–9. DOI: https://doi.org/10.1016/j.yebeh.2011.09.004 36. Wiglusz MS, Landowski J, Michalak L, et al. Validation of the Polish version of the Beck Depression Inventory in patients with epilepsy. Epilepsy Behav. 2017;77:58–61. DOI: https://doi.org/10.1016/j.yebeh.2017.09.023 37. de Oliveira GN, Lessa JM, Gonçalves AP, et al. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI). Epilepsy Behav. 2014;34:50–4. DOI: https://doi.org/10.1016/j.yebeh.2014.03.003 38. Beck A, Steer R, Brown G. Manual for Beck Depression Inventory-II. Psychological Corporation. San Antonio, TX: Psychological Corporation. 1996;1:82. 39. Beck C, Bernal H, Froman R. Methods to document semantic equivalence of a translated scale. Res Nurs Health. 2003;26(1):64–73. 40. Jones J, Hermann B, Woodard J, et al. Screening for Major Depression in Epilepsy with Common Self-report Depression Inventories. Epilepsia. 2005;46(5):731–5. DOI: https://doi.org/10.1111/j.1528-1167.2005.49704.x 41. Mintzer S, Lopez F. Comorbidity of ictal fear and panic disorder. Epilepsy Behav. 2002;3(4):330–7. DOI: https://doi.org/10.1016/s1525-5050(02)00045-8 42. Victoroff JI, Benson F, Grafton ST, et al. Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates. Arch Neurol. 1994;51(2):155–63. DOI: https://doi.org/10.1001/archneur.1994.00540140061016 43. Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5(5):399–405. DOI: https://doi.org/10.1016/S1474-4422(06)70415-X 44. Kim DH, Kim YS, Yang TW, et al. Optimal cutoff score of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) for detecting major depressive disorder: A meta-analysis. Epilepsy Behav. 2019;92:61–70. DOI: https://doi.org/10.1016/j.yebeh.2018.12.006 45. Rashid H, Katyal J, Tripathi M, et al. Validation of the Indian version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy Behav. 2019;95:75–8. DOI: https://doi.org/10.1016/j.yebeh.2018.12.006 46. Silagadze K, Kasradze S, Silagadze T, et al. Validation of a Georgian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy Behav. 2019;101(Pt. A):106587. DOI: https://doi.org/10.1016/j.yebeh.2019.106587 47. Gill S, Lukmanji S, Fiest K, et al. Depression screening tools in persons with epilepsy: A systematic review of validated tools. Epilepsia. 2017;58(5):695–705. DOI: https://doi.org/10.1111/epi.13651 48. Mula M. Developments in depression in epilepsy: screening, diagnosis, and treatment. Expert Rev Neurother. 2019;19(3):269–76. DOI: https://doi.org/10.1080/14737175.2019.1585244 49. Cengiz G, Tanık N. Validity and reliability of the Turkish version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy Behav. 2019;99:106471. DOI: https://doi.org/10.1016/j.yebeh.2019.106471 50. Metternich B, Wagner K, Buschmann F, et al. Validation of a German version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E). Epilepsy Behav. 2012;25(4):485–8. DOI: https://doi.org/10.1016/j.yebeh.2012.10.004 51. Ristić A, Pjevalica J, Trajković G, et al. Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) Serbian version. Epilepsy Behav. 2016;57(Pt. A):1–4. DOI: https://doi.org/10.1016/j.yebeh.2016.01.017 52. Brandt C, Labudda K, Illies D, et al. Schnelle Erkennung einer depressiven Störung bei Menschen mit Epilepsie. Der Nervenarzt. 2014;85(9):1151–5. DOI: https://doi.org/10.1007/s00115-013-3982-6 53. Zinchuk M, Kustov G, Pashnin E, et al. Validation of the Russian version of neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav. 2020;113:107549. DOI: https://doi.org/10.1016/j.yebeh.2020.107549 54. Xia N, Ding S, Lin J, et al. Comparison of the performance of two depression rating scales in patients with epilepsy in southern China. Epilepsy Behav. 2020;106:107025. DOI: https://doi.org/10.1016/j.yebeh.2020.107025 55. Mula M, McGonigal A, Micoulaud-Franchi JA, et al. Validation of rapid suicidality screening in epilepsy using the NDDIE. Epilepsia. 2016;57(6):949–55. DOI: https://doi.org/10.1111/epi.13373 56. Li Q, Zhu LN, Wang HJ, et al. Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDIE) as a rapid suicidality screening tool in Chinese people with epilepsy. Epilepsy Behav. 2019;94:216–21. DOI: https://doi.org/10.1016/j.yebeh.2019.03.024 57. Zinchuk MS, Avedisova AS, Pashnin EV, et al. [Suicidological research in epilepsy: problems of methodology]. Zh Nevrol Psikhiatr Im SS Korsakova. 2019;119(11–2):23–8. (In Russ.) DOI: https://doi.org/10.17116/jnevro201911911223 58. Abraham N, Buvanaswari P, Rathakrishnan R, et al. A meta-analysis of the rates of suicide ideation, attempts and deaths in people with epilepsy. Int J Environ Res Public Health. 2019;16(8):1451. DOI: https://doi.org/10.3390/ijerph16081451 59. Hesdorffer D, French J, Posner K, et al. Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia. 2013;54(5):879–87. DOI: https://doi.org/10.1111/epi.12128 60. Mula M, Kanner A, Schmitz B, et al. Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology. Epilepsia. 2013;54(1):199–203. DOI: https://doi.org/10.1111/j.1528-1167.2012.03688.x 61. Mula M, McGonigal A, Micoulaud-Franchi J, et al. Validation of rapid suicidality screening in epilepsy using the NDDIE. Epilepsia. 2016;57(6):949–55. DOI: https://doi.org/10.1111/epi.13373 62. Beyenburg S, Mitchell AJ, Schmidt D, et al. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav. 2005;7(2):161–71. DOI: https://doi.org/10.1016/j.yebeh.2005.05.014 63. Avedisova AS, Lebedeva AV, Pashnin EV, et al. [Anxiety disorders in epilepsy]. Zh Nevrol Psikhiatr Im SS Korsakova. 2018;118(10–2):37–44. (In Russ.) DOI: https://doi.org/10.17116/jnevro201811810237 64. Kanner AM, Schachter SC, Barry JJ, et al. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav. 2012;24(2):156–68. DOI: https://doi.org/10.1016/j.yebeh.2012.01.007 65. Wiglusz M, Landowski J, Cubała W. Validation of the Polish version of the Hospital Anxiety and Depression Scale for anxiety disorders in patients with epilepsy. Epilepsy Behav. 2018;84:162–5. DOI: https://doi.org/10.1016/j.yebeh.2018.04.010 66. Micoulaud-Franchi J, Lagarde S, Barkate G, et al. Rapid detection of generalized anxiety disorder and major depression in epilepsy: validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample. Epilepsy Behav. 2016;57(Pt. A):211–6. DOI: https://doi.org/10.1016/j.yebeh.2016.02.015 67. Seo J, Cho Y, Lee S, et al. Validation of the Generalized Anxiety Disorder-7 in people with epilepsy: A MEPSY study. Epilepsy Behav. 2014;35:59–63. DOI: https://doi.org/10.1016/j.yebeh.2014.04.005 68. Wang Z, Luo Z, Li S, et al. Anxiety screening tools in people with epilepsy: a systematic review of validated tools. Epilepsy Behav. 2019;99:106392. DOI: https://doi.org/10.1016/j.yebeh.2019.06.035 69. Kanner A. anxiety disorders in epilepsy: the forgotten psychiatric comorbidity. Epilepsy Curr. 2011;11(3):90–1. DOI: https://doi.org/10.5698/1535-7511-11.3.90 70. Krishnamoorthy E, Trimble M, Blumer D. The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav. 2007;10(3):349–53. DOI: https://doi.org/10.1016/j.yebeh.2006.10.002 71. Tong X, An D, McGonigal A, et al. Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Epilepsy Res. 2016;120:31–6. DOI: https://doi.org/10.1016/j.eplepsyres.2015.11.019 72. Hinz A, Klein A, Brähler E, et al. Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. J Affect Disord. 2017;210:338–44. DOI: https://doi.org/10.1016/j.jad.2016.12.012 73. Scott A, Sharpe L, Thayer Z, et al. Design and validation of two measures to detect anxiety disorders in epilepsy: The Epilepsy Anxiety Survey Instrument and its brief counterpart. Epilepsia. 2019;60(10):2068–77. DOI: https://doi.org/10.1111/epi.16348
DOI: http://dx.doi.org/10.47877/1560-957Х-2021-10309
Метрики статей
Metrics powered by PLOS ALM